Primo Nutraceuticals Inc.
BUGVF
OTC PK
| 04/30/2020 | 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | |
|---|---|---|---|---|---|
| Net Income | -320.70K | -64.50K | -385.70K | -3.28M | -108.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.50K | 25.90K | -- | 2.84M | 29.20K |
| Change in Net Operating Assets | 29.00K | -101.20K | 21.30K | 210.40K | 59.10K |
| Cash from Operations | -316.20K | -139.80K | -364.50K | -233.90K | -20.20K |
| Capital Expenditure | -- | -- | -- | 115.70K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.50K | 11.30K | -94.80K | -165.70K | -77.10K |
| Cash from Investing | -11.50K | 11.30K | -94.80K | -50.00K | -77.10K |
| Total Debt Issued | -- | -3.00K | 3.00K | 840.60K | 43.60K |
| Total Debt Repaid | 151.90K | 41.60K | -193.50K | -10.50K | -- |
| Issuance of Common Stock | 57.50K | 81.00K | 1.21M | -- | 248.00K |
| Repurchase of Common Stock | -- | -- | -- | -605.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 245.20K | 49.10K | -413.50K | 121.90K | -130.90K |
| Cash from Financing | 330.60K | 128.20K | 459.10K | 260.80K | 120.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.90K | -300.00 | -100.00 | -23.20K | 23.30K |
